Most published BPC-157 research is from animal studies, and large-scale human clinical trials are pending
Read More Thymosin Alpha A physician-guided peptide option often discussed in wellness and immune-support protocols
In preclinical models its reported effects concentrate at or near the site of administration, where it appears to promote new vessel formation, support fibroblast activity and stabilise the local healing environment
Follow-up labs monitor your response and guide dosing adjustments to ensure safety and efficacy
After 3 months, you'll take a reassessment, and your doctor will adjust your next protocol based on your progress
And in practical terms, that means this: when there is uncertainty, choose the route with more evidence, more transparency, and more supervision